Scalable, high-purity isolation of blood extracellular vesicles via a cleavable DNA–lipid anchor
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Extracellular vesicles (EVs) provide a protected molecular record of disease activity, but their potential as blood-based biomarkers has been limited by isolation methods that are slow, impure, and poorly scalable. We developed a cleavable DNA–lipid anchor (cDLA) that reframes EV isolation as a modular chemistry platform, enabling rapid, economical bead-based capture and release of intact vesicles. In plasma, cDLA achieved markedly higher purity than size-exclusion chromatography, delivering deeper proteomic coverage. We applied the approach to uncover vesicular tau signals that more faithfully tracked with cerebrospinal fluid, improving diagnostic discrimination over bulk plasma tau. cDLA provides a robust and clinically scalable method for EV isolation, opening a path to liquid biopsy in neurodegenerative diseases and beyond.
